Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients

Full text
Author(s):
Lima, Rodrigo Vieira Costa [1] ; Stefano, Jose Tadeu [1] ; Malta, Fernanda de Mello [1] ; Pinho, Joao Renato Rebello [1] ; Carrilho, Flair Jose [1] ; Arrese, Marco [2, 3] ; Oliveira, Claudia P. [1]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Lab Gastroenterol Clin & Expt LIM 07, Div Clin Gastroenterol & Hepat, Dept Gastroenterol, Hosp Clin HCFMUSP, Fac Med, BR-05403000 Sao Paulo, SP - Brazil
[2] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago 8330024 - Chile
[3] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Santiago 8330024 - Chile
Total Affiliations: 3
Document type: Journal article
Source: BIOMEDICINES; v. 9, n. 12 DEC 2021.
Web of Science Citations: 0
Abstract

Liver biopsy is the gold standard for assessing fibrosis, but there is a need to seek non-invasive biomarkers for this purpose. The aim of this study was to evaluate the correlation between the serum levels of the microRNAs miR-21, miR-29a, miR-122, miR-155 and miR-181a and the phenotypic expression of NAFLD. A cross-sectional study was carried out on 108 NAFLD patients diagnosed by liver biopsy. FIB-4 and NAFLD fibrosis scores were calculated. The comparison between the distributions of microRNA values according to the presence or absence of histological fibrosis (F2-F4) was performed. A multivariate logistic regression analysis was performed to build a score for predicting fibrosis using FIB-4 and Ln (miR-181a) as independent variables. Only miR-181a showed a statistical difference between patients with significant liver fibrosis (>F2) and those without (F0-F1) (p = 0.017). FIB-4 revealed an AUC on the ROC curve of 0.667 to predict clinically significant fibrosis (F2-F4). When assessed using the score in association with Ln (miR-181a), there was an improvement in the ROC curve, with an AUC of 0.71. miR-181a can be used as a non-invasive method of predicting fibrosis in NAFLD, and an association with FIB-4 has the potential to increase the accuracy of each method alone. (AU)

FAPESP's process: 18/03698-2 - The role of microRNAs in phenotipic expression of Non alcoholic fatty liver disease (NAFLD): since simple steatosis to hepatocellular carcinoma.
Grantee:Claudia Pinto Marques Souza de Oliveira
Support type: Regular Research Grants